Britain, Economic, European Union, Government, Politics, Scotland, Society

Treasonous myths of the Brexiteers’

BREXIT

JUST as an alliance with the EU is important to the UK, European immigrants are also vital to the British economy.

Many people will remember the insidious campaign during the EU referendum debate in 2016 of Nigel Farage standing in front of a poster showing a queue of refugees with the slogan: ‘Breaking point: The EU has failed us all’ – an image that was rightly compared to Nazi propaganda – while others were allowed to peddle the myth that EU immigration had helped to cause austerity. It must surely be a matter of profound regret among leaders of the Remain campaign that they allowed the effects of immigration to be so utterly misrepresented in the run-up to the Brexit vote.

Since that fateful day, various employers appear to have woken up to the serious risks posed by a shortage of labour if the UK leaves the Single Market and ditches freedom of movement (as Theresa May insists will happen).

The latest sign of trouble comes from our schools, with the number of teachers from other EU countries – like Greece, Poland, Spain and Ireland – applying to work in Scotland “falling off a cliff”.

In 2017, some 186 teachers from the EU sought registration with the General Teaching Council for Scotland, but so far this year just 14 have done so. This comes at a time of teacher shortages with some 700 vacancies in Scotland at the start of the year.

Nine out of ten UK employers report they are struggling to recruit staff with the skills they need, threatening the ability of the UK economy to compete. Wages could rise as employers are forced to compete for a smaller pool of available workers, but this may prove to be a short-lived boon if firms with fewer skilled staff and higher costs start to lose business and trade to their EU rivals.

The economic chaos that could be caused by a no-deal Brexit could further exacerbate what is already an alarming situation.

What is equally important is the attitude adopted by our elected politicians towards the EU, described recently by President Trump as a “foe” while he cosied up to Vladimir Putin of Russia.

In a further twist and wholly unacceptable language, Conservative MEP David Campbell-Bannerman has claimed the Treason Act should be amended to apply to “those in future actively working undemocratically against the UK through extreme EU loyalty” because, “like extreme jihadis”, they were “seeking to destroy or undermine the British state”.

We should have welcomed immigrants to this country by freely acknowledging the massive contribution they have made to our society, but instead we have turned them into scapegoats for austerity. What a pitifully poor and degrading accusation.

Now there is a serious risk of another dangerous myth gaining a foothold in the public’s imagination – that the friendly democracies of the EU are in some way our enemy.

BRITAIN will be unable to forge a new trade deal with fast-growing Pacific countries unless it makes a clean break with the EU, a report has warned.

The Government’s White Paper on Brexit says the UK will “potentially seek accession” to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) after leaving the EU.

The 11-member organisation, which aims to eliminate 98 per cent of all tariffs, is seen as a major potential growth market.

But a study by the Policy Exchange thinktank warns that Theresa May’s Chequers deal could make membership impossible.

The controversial deal commits the UK to following a “common rulebook” with the EU on goods and farm products, limiting the room for manoeuvre with trade negotiators.

The report warns that joining the partnership would require the UK to have more flexibility over its regulations.

Report author Geoff Raby, a former Australian ambassador to the World Trade Organisation, said: “By aligning UK policy to EU policy on agriculture and manufactured goods, the White Paper will constrain the opportunities that the UK has to pursue an independent trade policy.

“Without being able to participate fully in the agricultural and manufactured goods dimension it is most unlikely that the UK would be able to join, but if it did it would not be able to get the full benefits.”

The Chequers deal has caused uproar in the Conservative Party and prompted the resignations of Boris Johnson and David Davis.

The PM has insisted that it will not constrain the UK’s future trade policy. She told MPs this month: “We specifically looked at whether the plan that we were putting forward would enable us to accede to the comprehensive and progressive agreement for Trans-Pacific Partnership, and it will.”

But the report threatens to reopen the row over the potential impact on trade of the Chequers agreement. Donald Trump has warned that the restrictions would “kill” hopes of a US trade deal – although he rowed back following talks with Mrs May.

The CPTPP’s members include Australia, Canada, Japan, Mexico and New Zealand, with South Korea, Indonesia and Taiwan among those set to join.

Policy Exchange chairman Alexander Downer, the former Australian high commissioner to the UK, said Britain would be “a welcome addition” to the bloc, which would give it “unfettered access to many markets that represent a large part of the future of the world’s economy”.

Standard
Health, Medical, Research, Science

Could a new ‘universal vaccine’ stop all strains of flu virus?

MEDICAL RESEARCH

A NEW universal long-lasting vaccine could prevent the need for yearly flu jabs.

Currently, scientists have to predict every year what the new strain of flu will look like, but by the time the vaccine has been made, the strain of virus may already have mutated and changed.

Recently released figures reveal the vaccine given to ten million over-65s, children and at-risk adults last year offered little protection against the killer H3N2 strain, known as Aussie flu, which put unprecedented pressure on the NHS during the winter months.

Public Health officials have admitted the jab had “no significant effectiveness” in preventing people from being struck down – and was deemed only 15 per cent effective overall.

UK researchers are now working on a “universal” vaccine to protect against a number of strains.

The cells of the flu virus are like spherical cushions with lots of pins sticking out. Flu vaccines currently work by triggering an immune response to antigens – the heads of the pins – on the cell’s surface.

The immune system creates antibodies, which are then primed to attack and block the real flu virus when it comes along: the antibodies recognise the virus by its antigens.

The new vaccine, developed at the University of Oxford, protects the body against flu in a way that makes it more universal.

 

SCIENTISTS have found that while flu strains vary, all flu viruses contain epitopes (parts of the antigen to which antibodies attach), which vary much less than previously thought. Targeting these epitopes through vaccination would protect against all strains of the virus.

The new vaccine is designed to home in on these common epitopes and help the immune system create antibodies to fight them.

So far they’ve identified specific epitopes for two main types of flu – influenza A virus (subtypes H1 and H3) and influenza B. Researchers say a vaccine using this new approach could provide immunity without the need for yearly vaccinations, and could work against many types of flu even if the virus mutates.

Two or three injections would give long-term protection against different strains, they say.

Sunetra Gupta, a professor of theoretical epidemiology who led the research, says: “We believe our methods can be applied to produce vaccines against all subtypes of influenza, thereby providing the opportunity to develop not only a more effective vaccine against endemic influenza, with lower healthcare costs, but also better protection against potential influenza pandemics.

“The same strategy can also be used to produce vaccines for swine and avian influenza, which will have significant economic consequences, and the control of which will reduce the probability of new lineages emerging with pandemic potential.”

Vaccination is the most effective way to protect against the virus and is given annually in the UK to people at risk, including the over-65s, children aged two to nine, pregnant women, and people in long-stay residential care homes.

But the problem with existing vaccines is that the flu virus frequently mutates in two ways.

The first, known as antigenic drift, involves small changes in the genes of influenza viruses as the virus replicates.

These small genetic changes usually produce viruses that are closely related to one another, and share the same antigenic properties, so an immune system exposed to a similar virus will usually recognise it and respond.

But these small changes can accumulate over time and eventually the immune system may not recognise them and respond.

The less common route is antigenic shift – an abrupt, major change in the influenza A virus, and most people have little or no protection against the new virus.

 

TO ENSURE vaccines are available when needed, six months before the flu season, scientists try to predict the new strain. However, as the latest figures show, they don’t always get it right.

Commenting on the research, Professor Wendy Barclay, the Action Medical Research Chair in Virology at Imperial College London, says: “There are lots of different ideas about to make a universal flu vaccine and how universal it would actually be.

“This work from the Oxford group would mean we don’t have to update the flu vaccine yearly, but if a new pandemic came along, chances are this type of vaccine wouldn’t work against that.

“But it would mean we don’t have to chase after the virus as it constantly drifts and we try to keep up.”

Standard
Health, Medical, Research, Science

Blood pressure study linked to dementia

MEDICAL RESEARCH

A major study suggests that hundreds of thousands of people could be saved from dementia if blood pressure tablets were used more widely.

Researchers have shown for the first time that aggressively treating high blood pressure – particularly in middle age – could also significantly reduce the risk of dementia later on.

NHS officials are under growing pressure to lower the threshold at which people can be given the drugs, a policy that could make 14million eligible for treatment.

Patients are currently considered to have hypertension – or high blood pressure – only if they have a reading of more than 140/90 mm Hg.

But a study of 9,400 people in the US found cutting the systolic threshold – the higher reading – to 120 instead of 140 slowed cognitive decline.

An ideal blood pressure reading is between 90/60 millimetres of mercury (mm Hg) and 120/80. The first figure is the systolic pressure, the “surge” that occurs with each heartbeat. The second is the diastolic reading, which measures the pressure in the “rest” between heartbeats.

Using the new threshold over eight years reduced rates of dementia and mild cognitive impairment by 15 per cent, according to results presented at the Alzheimer’s Association International Conference in Chicago.

Similar trials have shown cutting the threshold for treatment would reduce the risk of heart disease by a fifth, and strokes by about a quarter.

Health watchdogs are already reviewing blood pressure guidelines with a view to cutting rates of heart disease and a decision is expected next year.

But they will now face greater pressure to change the rules after the new research, the first to look in detail at the impact of such a policy on dementia.

Study leader Professor Jeff Williamson, of the Wake Forest School of Medicine in North Carolina, said: “These results support the need to maintain well-controlled blood pressure, especially for persons over 50.”

A second study of 670 patients by the University of Pennsylvania found that the lower threshold also showed shrinkage of white brain matter, strengthening the link between blood pressure and dementia.

The US has led the way on blood pressure policy, lowering the treatment threshold in November from a systolic score of 140 to 130.

If the UK followed suit, it would mean an estimated 14million people – a third of all adults – would be eligible. Currently seven million are eligible.

A policy to increase this, however, would be controversial as it would affect many people who until now have been considered healthy. A similar change that lowered the threshold for cholesterol-busting statin drugs in 2014 led to a huge backlash, fueling accusations that health professionals were “over-medicalising” the middle aged.

A spokesperson for Alzheimer’s Research UK, said: “This study suggests treating high blood pressure intensively . . . may help to reduce the risk of memory and thinking problems.

“There is robust evidence that what’s good for the heart is also good for the brain and maintaining good vascular health is one of the key things people can do to reduce their risk of dementia.”

But Professor Clive Ballard, of Exeter University, warned: “All anti-hypertensives come with some risk of adverse effects, most seriously for kidney function.”

 

THOSE who feel light-headed when standing up after a long time sitting may be at a greater risk of dementia and stroke, according to a US study of more than 11,000 people.

Scientists at John Hopkins University found those whose blood pressure dropped when they stood up – a problem known as orthostatic hypotension – had twice the risk of suffering a stroke in later life. Their risk of dementia was 54 per cent higher.

Standard